• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug survival of apremilast in patients treated for psoriasis in a real-world setting.

作者信息

Lee Erica B, Amin Mina, Wu Jashin J

机构信息

John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.

University of California, Riverside, School of Medicine, Riverside, California.

出版信息

J Am Acad Dermatol. 2018 Oct;79(4):760-761. doi: 10.1016/j.jaad.2018.03.028. Epub 2018 Mar 26.

DOI:10.1016/j.jaad.2018.03.028
PMID:29588246
Abstract
摘要

相似文献

1
Drug survival of apremilast in patients treated for psoriasis in a real-world setting.在真实临床环境中接受治疗的银屑病患者中阿普米司特的药物留存率
J Am Acad Dermatol. 2018 Oct;79(4):760-761. doi: 10.1016/j.jaad.2018.03.028. Epub 2018 Mar 26.
2
Maintenance of therapeutic response after 1 year of apremilast combination therapy compared with monotherapy for the treatment of plaque psoriasis: A multicenter, retrospective study.与阿普米司特单药治疗相比，阿普米司特联合治疗1年后斑块状银屑病治疗反应的维持情况：一项多中心回顾性研究。
J Am Acad Dermatol. 2018 Nov;79(5):953-956. doi: 10.1016/j.jaad.2018.04.043. Epub 2018 May 4.
3
Apremilast in psoriasis - a prospective real-world study.阿普米司特治疗银屑病-一项前瞻性真实世界研究。
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):254-259. doi: 10.1111/jdv.14598. Epub 2017 Oct 12.
4
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2).阿普米司特，一种口服磷酸二酯酶 4 抑制剂，用于治疗难治性指甲和头皮银屑病患者：两项 III 期随机对照试验（ESTEEM 1 和 ESTEEM 2）的结果。
J Am Acad Dermatol. 2016 Jan;74(1):134-42. doi: 10.1016/j.jaad.2015.09.001.
5
Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis.阿普米司特治疗中重度斑块型银屑病的真实世界疗效和安全性数据。
J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1173-1179. doi: 10.1111/jdv.14832. Epub 2018 Mar 30.
6
Cutaneous hyperpigmentation induced by apremilast.阿普司特引起的皮肤色素沉着过度。
Int J Dermatol. 2018 Apr;57(4):473-474. doi: 10.1111/ijd.13831. Epub 2018 Jan 19.
7
Real-world data on the efficacy and safety of apremilast in Japanese patients with plaque psoriasis.真实世界中阿普米司特治疗日本斑块状银屑病患者的疗效和安全性数据。
J Dermatolog Treat. 2019 Jun;30(4):383-386. doi: 10.1080/09546634.2018.1525480. Epub 2018 Oct 8.
8
Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis.甲氨蝶呤初治银屑病患者中，甲氨蝶呤与阿普米司特的疗效比较和应答者增量成本。
J Am Acad Dermatol. 2016 Oct;75(4):740-746. doi: 10.1016/j.jaad.2016.05.040. Epub 2016 Jul 28.
9
Real-world use of apremilast for patients with psoriasis in Japan.日本银屑病患者阿普米司特的真实世界应用。
J Dermatol. 2018 Nov;45(11):1345-1348. doi: 10.1111/1346-8138.14617. Epub 2018 Aug 31.
10
Real-World Experience With Apremilast in Treating Psoriasis.阿普米拉斯治疗银屑病的真实世界经验。
J Cutan Med Surg. 2017 Mar/Apr;21(2):145-151. doi: 10.1177/1203475416676030. Epub 2016 Oct 23.

引用本文的文献

1
Characteristics and outcomes of patients with psoriasis treated with apremilast in the real-world in Austria - results the APPRECIATE study.奥地利真实世界中接受阿普米司特治疗的银屑病患者的特征与结局——APPRECIATE研究结果
Ther Adv Chronic Dis. 2023 Feb 7;14:20406223231152785. doi: 10.1177/20406223231152785. eCollection 2023.
2
Apremilast Survival and Reasons for Discontinuation in Psoriasis: Five-Year Experience From a Greek Tertiary Care Centre.阿普米拉斯在银屑病中的生存率及停药原因：来自希腊三级护理中心的五年经验
Dermatol Pract Concept. 2022 Jan 1;12(2):e2022076. doi: 10.5826/dpc.1202a76. eCollection 2022 May.
3
The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios.
阿普米拉斯在银屑病治疗中的应用：印度对现实世界情况的看法。
Psoriasis (Auckl). 2021 Aug 14;11:109-122. doi: 10.2147/PTT.S320810. eCollection 2021.
4
Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature.银屑病口服全身治疗的长期安全性：文献综述
Dermatol Ther (Heidelb). 2020 Aug;10(4):589-613. doi: 10.1007/s13555-020-00409-4. Epub 2020 Jun 11.
5
Apremilast in Psoriasis and Beyond: Big Hopes on a Small Molecule.阿普司特治疗银屑病及其他疾病：对一种小分子药物寄予厚望
Indian Dermatol Online J. 2019 Jan-Feb;10(1):1-12. doi: 10.4103/idoj.IDOJ_437_18.